DC Attorney General Seeks More Time as GW Physician Group Transfer Review Continues
The District of Columbia’s Office of the Attorney General has asked a court to extend its review of George Washington University’s physician group transfer to a nonprofit controlled by Universal Health Services. The request adds another procedural layer to a transaction already marked by financial strain, regulatory scrutiny, and a dispute over whether the office has authority to weigh in on the deal at all.
The transfer centers on the Medical Faculty Associates, George Washington University’s physician group, and its planned move to Capital Medical Group, a nonprofit physician organization whose sole member is a UHS entity. GW and the King of Prussia, Pa.-based health system reached a definitive agreement in May. Under the arrangement, most MFA physicians and staff would move to CMG, while UHS would assume full financial responsibility for clinical practice operations.
The structure is unusual but not opaque. GW is committing up to $230 million to support the transition and to absorb prior loans to MFA, which has lost more than $450 million since 2022. In practical terms, the deal functions as both a rescue effort and a handoff: one organization is trying to stabilize a financially distressed clinical enterprise while another steps in to run operations under a nonprofit banner.
Financial distress is not a side issue here. It sits at the center of the transaction and helps explain why the clinical group is being moved rather than simply restructured in place.
Regulatory Scrutiny Under the District’s Conversion Law
The attorney general opened the investigation in April under the District’s Healthcare Entity Conversion Act, which requires office approval before a for-profit company can take control of a nonprofit healthcare entity in Washington, D.C. That statute is designed to give the District a formal role when control of a healthcare institution changes hands in ways that could affect access, governance, and community benefit.
On July 27, the office filed a civil complaint in D.C. Superior Court against GW, MFA, CMG, and UHS, alleging the parties delayed turning over documents needed for the review. The same day, both sides reached an agreement that allowed the deal to close operationally on July 31 while the review continued. Under that agreement, the office had until at least Sept. 30 to approve the transfer, reject it, or approve it with conditions. UHS also agreed to pay the District $610,000 for delays in the review process.
CMG began providing clinical services to MFA patients on Aug. 1, so the operational transition is already underway even as legal review remains active. That split between clinical continuity and regulatory clearance gives the case its immediate tension: care delivery has moved forward, but the transfer itself is still under formal scrutiny.
Jurisdiction Remains the Core Dispute
GW, MFA, and UHS have disputed the attorney general’s jurisdiction over the transaction, while also stating they will cooperate with the review. That position leaves the parties in a familiar but uncomfortable posture. They are acting as though the process matters, while reserving the right to argue that the office should not be deciding it in the first place.
A university official told the Hatchet in July that GW believes it has a strong case for approval. The stated rationale rests on two pillars: protections for continuity of patient care and MFA’s financial condition. If the transfer is blocked, the parties would work with the office to address reasonable concerns or ask the court to intervene if they viewed the decision as unreasonable.
The legal question and the clinical question overlap, but they are not identical. Regulators are examining who should control the physician group and whether the transaction complies with District law. Clinicians and patients are looking at whether staffing, scheduling, and continuity of care remain intact during the transition. When a physician enterprise is operating at a loss of more than $450 million over a two-year span, governance disputes can quickly become bedside issues.
Why This Transaction Matters for Patients and Physicians
Physician group conversions often sound like corporate housekeeping until the effects reach clinics, exam rooms, and call schedules. Here, the concern is straightforward: if most MFA physicians and staff move to CMG, the handoff must preserve clinical access while shifting responsibility for operations to a new entity. That means the legal structure of the deal has direct implications for where patients are seen, who manages the practice, and how quickly the new operator can absorb the existing workforce.
The financial terms make the scale of the problem easier to understand. GW’s willingness to provide up to $230 million suggests that the university sees the transition as necessary to stabilize a group that has already accumulated substantial losses. UHS’s assumption of full financial responsibility indicates that the new operator is not merely lending administrative support; it is taking on a business with serious structural deficits.
In healthcare terms, this is a controlled transfer of risk as much as a transfer of ownership and operations. The question regulators must answer is whether that risk is being managed in a way that protects patients, staff, and the public interest.
The Next Decision Will Shape the Deal’s Final Form
The attorney general’s office has asked the court for more time, but the reason for the extension and its length have not been disclosed. That silence leaves the timeline uncertain even though the operational move has already started. If the office ultimately approves the transfer, it could do so outright or with conditions. If it rejects the deal, the parties have already signaled that they may seek further resolution through negotiation or the courts.
For now, the transaction remains caught between financial necessity and public oversight. GW has already agreed to absorb past loans and contribute up to $230 million. UHS has already taken on operational responsibility through CMG. The attorney general’s office is still deciding whether the transfer should stand, and the requested extension suggests that review is not yet close to finished.